23rd Jul 2019 12:17
(Alliance News) - RenalytixAI PLC on Tuesday announced a planned share placing to raise GBP12.0 million to go towards two key products.
RenalytixAI, which develops artificial intelligence-using diagnostics for kidney disease, will place 4.8 million new shares at a price of 250 pence each. RenalytixAI was 4.4% lower on Tuesday at 263.00p each.
Much of the funding will go towards development KidneyIntelX, though some will go towards another product, FractalDx, and some also towards working capital.
The placing will be run by N+1 Singer Advisory LLP and Stifel Nicolaus Europe Ltd.
Related Shares:
Renalytix Plc